PURE Bioscience Receives USDA No Objection Letter for Use of SDC-Based PURE Control Antimicrobial
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced it has received a “No Objection Letter” from the USDA’s Food Safety and Inspection Service (FSIS) granting approval for SDC-based PURE Control to be used as a spray or dip applied to poultry carcasses, parts and organs in pre-OLR (on-line reprocessing) and post chill processing of fresh poultry. PURE Control was just listed in FSIS’ Directive 7120.1, “Safe and Suitable Ingredients Used in the Production of Meat, Poultry and Egg Products” in the August 25th published revision.
The commercialization of PURE Control for these newly approved applications is underway and the company is already in discussions with several major poultry processors to begin in-plant validation and optimization testing.
The approval for these new uses allows immediate access to multiple poultry processing application points outside of OLR and enables PURE to begin sales to poultry processors. The PURE Control product allows harmful pathogens to be neutralized in the processing stage, before products are shipped to end-users.
Hank R. Lambert, Chief Executive Officer, says, “We are pleased to achieve another important milestone in our strategy to introduce our game changing SDC technology to poultry processors. With this ‘No Objection Letter’ and 7120.1 listing in hand, we are moving forward with several of the top poultry processors to evaluate using PURE Control in their plants. As with each first time user of PURE Control, that process will include in-plant validation and optimization analysis over the next few months.”
PURE continues its on-going plant trials to optimize the application of PURE Control in OLR to gain USDA approval for use in that stage of poultry processing and anticipates completion in the fourth calendar quarter this year.